Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Eunice Park

Physician Assistant, Medical Puyallup, WA Physician Assistant

NPI 1366911604 CMS profile 11192914

1703 S Meridian Ste 101, Puyallup, WA 98371

Open in the dashboard

General payments

$5,870

296 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Eunice Park of Puyallup, WA is reported in the CMS Open Payments database as having received $5,870 across 296 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 90th percentile of Physician Assistant, Medical profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,270 84
2024 General $1,697 62
2023 General $1,377 57
2022 General $672 32
2021 General $854 61

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Eunice Park
  • Physician Assistant, Medical median
  • Middle half of Physician Assistant, Medical
  • National median

In program year 2025, general payments to Eunice Park were reported at $1,270. Among 16,675 Physician Assistant, Medical profiles paid that year, the median was $214 and the middle half received between $62 and $755.

Show as a table
Year Eunice Park Physician Assistant, Medical median Middle half National median
2019 $0 $61 $19–$193 $163
2020 $0 $20 $14–$64 $114
2021 $854 $156 $41–$563 $132
2022 $672 $185 $55–$649 $149
2023 $1,377 $199 $58–$717 $160
2024 $1,697 $206 $62–$740 $164
2025 $1,270 $214 $62–$755 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Janssen Biotech, Inc. $1,246 83 payments
  2. AbbVie, Inc. $1,036 68 payments
  3. E.R. Squibb & Sons, L.L.C. $639 18 payments
  4. Amgen Inc. $563 26 payments
  5. Sun Pharmaceutical Industries Inc. $434 18 payments
  6. Genzyme Corporation $392 11 payments
  7. Novartis Pharmaceuticals Corporation $271 19 payments
  8. UCB, Inc. $258 8 payments
  9. Pfizer Inc. $223 15 payments
  10. Regeneron Healthcare Solutions, Inc. $161 3 payments
  11. Other $647 27 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $5,860 295 payments
  2. Education $10 1 payment
Products named General payments · program years 2021–2025
  1. TREMFYA $1,201 70 payments
  2. SOTYKTU $639 18 payments
  3. Otezla $563 26 payments
  4. DUPIXENT $542 13 payments
  5. SKYRIZI Immunology $370 26 payments
  6. ILUMYA $355 14 payments
  7. SKYRIZI Immunology $304 23 payments
  8. RINVOQ $289 15 payments
  9. Bimzelx $239 7 payments
  10. CIBINQO $197 12 payments
  11. Other $1,953 123 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 17 drugs

Part D claims

571

Median for Physician Assistant: 241

Drug cost

$90,264

Median for Physician Assistant: $4,110

Branded share of claims

6%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Otezla Apremilast Brand 14 $75,020
Clobetasol Propionate Generic 95 $3,965
Metronidazole Generic 46 $2,218
Fluorouracil Generic 33 $2,025
Tacrolimus Generic 17 $1,637
Ketoconazole Generic 135 $1,637
Calcipotriene Generic 13 $1,449
Triamcinolone Acetonide Generic 75 $691
Clindamycin Phosphate Generic 17 $431
Doxycycline Monohydrate Generic 11 $365

The 10 drugs with the highest cost, of 17 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 49 billing codes

Paid by Medicare

$120,956

Of which drugs: $11,588

Medicare patients

556

Average age 75

Services billed

3,059

365 women, 191 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 60%
Arthritis 43%
Diabetes 25%
Ischemic heart disease 21%
Chronic kidney disease 16%
Atrial fibrillation 15%
Osteoporosis 15%
Cancer 13%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) J7308 Office 12 38 $11,571
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 14 22 $18

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 18 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
SOTYKTU
  • E.R. Squibb & Sons, L.L.C. $393
$393 — —
TREMFYA
  • Janssen Biotech, Inc. $303
$303 — —
SKYRIZI
  • AbbVie, Inc. $196
$196 — —
Bimzelx
  • UCB, Inc. $186
$186 — —
VTAMA
  • Dermavant Sciences, Inc. $118
$118 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 18 in the dashboard with a free account

Records

296 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant, Medical in Washington

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record